Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sujeet K Rajan

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Lung India : Official Organ of Indian Chest Society|November 8, 2014
Ease-of-use, preference, confidence, and satisfaction with Revolizer(®), a novel dry powder inhaler, in an Indian populationSujeet K Rajan, Jaideep A Gogtay
Lung India : Official Organ of Indian Chest Society|July 14, 2021
Placing the results of the SOLIDARITY trial with regards to remdesivir in perspectiveDebdipta Bose, Nithya Jaideep Gogtay, Sujeet K Rajan
Expert Review of Respiratory Medicine|November 11, 2021
The emerging role of mycophenolate mofetil in interstitial lung diseasesKevin K Brown, Sujeet K Rajan, Padmanabha Shenoy, et al.
The Lancet. Respiratory Medicine|October 7, 2022
Home monitoring in interstitial lung diseasesMarlies S Wijsenbeek, Catharina C Moor, Kerri A Johannson, et al.
The European Respiratory Journal|December 14, 2022
Progressive pulmonary fibrosis: an expert group consensus statementSujeet K Rajan, Vincent Cottin, Raja Dhar, et al.
American Journal of Respiratory and Critical Care Medicine|March 30, 2022
Integrating Clinical Probability into the Diagnostic Approach to Idiopathic Pulmonary Fibrosis: An International Working Group PerspectiveVincent Cottin, Sara Tomassetti, Claudia Valenzuela, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Lung India : Official Organ of Indian Chest Society|November 8, 2014
Ease-of-use, preference, confidence, and satisfaction with Revolizer(®), a novel dry powder inhaler, in an Indian populationSujeet K Rajan, Jaideep A Gogtay
Lung India : Official Organ of Indian Chest Society|July 14, 2021
Placing the results of the SOLIDARITY trial with regards to remdesivir in perspectiveDebdipta Bose, Nithya Jaideep Gogtay, Sujeet K Rajan
Expert Review of Respiratory Medicine|November 11, 2021
The emerging role of mycophenolate mofetil in interstitial lung diseasesKevin K Brown, Sujeet K Rajan, Padmanabha Shenoy, et al.
The Lancet. Respiratory Medicine|October 7, 2022
Home monitoring in interstitial lung diseasesMarlies S Wijsenbeek, Catharina C Moor, Kerri A Johannson, et al.
The European Respiratory Journal|December 14, 2022
Progressive pulmonary fibrosis: an expert group consensus statementSujeet K Rajan, Vincent Cottin, Raja Dhar, et al.
American Journal of Respiratory and Critical Care Medicine|March 30, 2022
Integrating Clinical Probability into the Diagnostic Approach to Idiopathic Pulmonary Fibrosis: An International Working Group PerspectiveVincent Cottin, Sara Tomassetti, Claudia Valenzuela, et al.
Pageof 1